Tarpeyo, the brand name for budesonide delayed-release capsules, is a corticosteroid. It helps lessen the worsening of kidney function in adults with a kidney condition called immunoglobulin A nephropathy (IgAN). Tarpeyo (budesonide) is taken by mouth once daily in the morning on an empty stomach. Some possible side effects include swelling in the arms and legs, high blood pressure, and weight gain.
Lessening the worsening of kidney function in adults with a kidney condition called immunoglobulin A nephropathy (IgAN)
Tarpeyo (budesonide) is a corticosteroid, or also known as a "steroid." It stops certain immune cells in the body from making proteins called immunoglobulin A (IgA) antibodies. This helps stop protein buildup in the kidneys, which helps prevent more damage to the kidneys and worsening of immunoglobulin A nephropathy (IgAN).
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
A possible option for people who've already tried other therapies
Taken once per day
Taken by mouth
Must take 4 capsules for each dose
Should take in the morning on an empty stomach
Can cause unpleasant side effects (e.g., weight gain, muscle spasms)
Take Tarpeyo (budesonide) in the morning, at least 1 hour before your meal.
You'll need to take 4 capsules of Tarpeyo (budesonide) for each dose. Swallow each capsule whole. Don't open, crush, break, or chew them because it can damage the medication and affect how it works in your body.
You'll typically need to take Tarpeyo (budesonide) for 9 months. But depending on your kidney condition and any side effects you might have from the medication, your prescriber might tell you to take Tarpeyo (budesonide) for a different length of time.
Take Tarpeyo (budesonide) exactly as prescribed. Don't stop taking your medication unless your prescriber tells you to. Stopping Tarpeyo (budesonide) suddenly can cause withdrawal symptoms, such as nausea, weakness, and body aches. Speak with your prescriber if you'd like to stop treatment for more instructions.
Avoid grapefruit and grapefruit juice while you're taking Tarpeyo (budesonide). Grapefruit can raise the levels of the medication in your body, which can put you at risk for side effects like headache or acne.
Avoid alcohol while you're taking Tarpeyo (budesonide). Both alcohol and Tarpeyo (budesonide) can weaken your immune system, which can raise your risk for infections. If you drink alcohol regularly, talk to your prescriber or a healthcare professional. They can recommend ways to quit alcohol.
Share an up-to-date medication list with your care team. They can check that your medications are safe to take with Tarpeyo (budesonide). Examples of medications that can interact with Tarpeyo (budesonide) include those that weaken your immune system, ritonavir, erythromycin, and cyclosporine (Neoral).
Tarpeyo (budesonide) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Risk factors: Taking Tarpeyo (budesonide) for a long time | Liver problems
Steroids such as Tarpeyo (budesonide) act like the stress hormone cortisol that your body naturally makes. When you take steroid medications for a long time, your body can start to make less of its own cortisol and rely more on the steroid medication instead. This can cause changes in the stress hormone levels in your body.
When you're taking steroid medications for a long period of time, it's possible for you to have symptoms that look like you have too much stress hormone in the body. These symptoms include easy bruising, rounding of the face, more fat between the shoulders or back of the neck, weak muscles, and weight gain.
And if you stop taking Tarpeyo (budesonide) all of a sudden, you might have symptoms of low stress hormone levels, such as weakness, nausea, and body aches. These symptoms happen because the body hasn't had enough time to start making its own cortisol again. But they should go away over time as your natural cortisol level returns to normal. Your prescriber will give you instructions to safely stop Tarpeyo (budesonide), if needed.
Tarpeyo (budesonide) can weaken your immune system and raise your risk of infections. Let your prescriber know if you currently have any infections or if you've recently traveled (some areas have a high risk for infections). Also tell them if you've had tuberculosis (TB) or hepatitis B in the past because these infections might come back while you're taking Tarpeyo (budesonide).
Contact your primary care provider or call urgent care if you start to have any symptoms of an infection while you're taking Tarpeyo (budesonide). Look out for fever, tiredness, chills, cough, and trouble breathing.
Risk factors: High blood pressure | High blood sugar (diabetes) | Osteoporosis (weakened bones) | Stomach ulcer | Glaucoma | Cataracts | Family history of diabetes or glaucoma
Steroids like Tarpeyo (budesonide) can worsen certain medical conditions and cause unwanted effects. It can raise blood pressure and blood sugar. It can also raise the risk for bone weakening (osteoporosis), stomach ulcers, and eye problems (e.g., glaucoma, cataracts).
Make sure your prescriber knows about all the medical conditions you have before you start Tarpeyo (budesonide). They check that the medication is safe for you to take.
Each Tarpeyo delayed-release capsule contains 4 mg of budesonide.
The typical dose is 4 capsules by mouth once daily in the morning at least 1 hour before breakfast. It's recommended to take Tarpeyo (budesonide) for 9 months.
Allergic reaction to any other budesonide medications
Lessening the worsening of kidney function in adults with a kidney condition called immunoglobulin A nephropathy (IgAN)
Lower urine protein levels in adults with immunoglobulin A nephropathy (IgAN)
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Calliditas Therapeutics. (2023). Calliditas Therapeutics announces full FDA approval of Tarpeyo®, the only FDA-approved treatment for IgA nephropathy to significantly reduce the loss of kidney function.
Calliditas Therapeutics AB. (2024). Tarpeyo- budesonide capsule, delayed release [package insert]. DailyMed.
Caster, D. J., et al. (2023). The treatment of primary IgA nephropathy: Change, change, change. American Journal of Kidney Diseases.
IgA Nephropathy Foundation. (n.d.). IgAN FAQs.
MedlinePlus. (2024). White blood count (WBC).
National Institute of Diabetes and Digestive and Kidney Diseases. (2018). Cushing’s syndrome.
National Kidney Foundation. (2024). IgA nephropathy.
U.S. Food and Drug Administration. (2021). FDA approves first drug to decrease urine protein in IgA nephropathy, a rare kidney disease.
Your and Your Hormones. (2019). Cortisol.
Zeng, Q., et al. (2023). Diagnostic and prognostic value of galactose-deficient IgA1 in patients with IgA nephropathy: An updated systematic review with meta analysis. Frontiers in Immunology.
Zhang, H., et al. (2024). Efficacy and safety of Nefecon in patients with IgA nephropathy from mainland China: 2-year NefIgArd trial results. Kidney360.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.